Ardsley Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History

Ardsley Advisory Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,000	Closed	-$1.3M	–	174
2016 Q1	$1.3M	Buy	+15,000	New	+$1.34M	0.2%	56

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ardsley Advisory Partners's IBB Position: Q2 2020 in Review

Ardsley Advisory Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 7,000 shares — an estimated $754K sold.

Ardsley Advisory Partners first reported a position in IBB in Q1 2016 and held it in 16 quarters. The position peaked at $1.87M in Q4 2017. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Ardsley Advisory Partners reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 7,000 iShares Biotechnology ETF shares in Q2 2020, an estimated $754K.
Ardsley Advisory Partners first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 16 quarters.
Ardsley Advisory Partners's iShares Biotechnology ETF position peaked at $1.87M in Q4 2017.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Ardsley Advisory Partners's 13F filing for Q2 2020, filed 14 Aug 2020.